Yatharth hospital & Trauma Care Services Limited has scheduled its quarterly earnings conference call to discuss Q3FY26 financial results. The company informed stock exchanges through a regulatory filing dated February 2, 2026, announcing the call details under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

Conference Call Schedule

The earnings conference call is scheduled for February 6, 2026, at 1:00 PM IST. The call will take place after the declaration of the company's unaudited financial results for the quarter ended December 31, 2025.

Management Participation

The conference call will feature key management personnel from Yatharth Hospital & Trauma Care Services Limited:

• Mr. Yatharth Tyagi – Whole-Time Director
• Mr. Amit Kumar Singh – Group Chief Executive Officer
• Mr. Nitin Gupta – President, Finance & Group Chief Operating Officer
• Mr. Pankaj Prabhakar – Group Chief Financial Officer
• Mr. Ashutosh Kumar Jha – Group Chief - Strategy, M&A and Investor Relations
• Mr. Sonu Goyal – Group Financial Controller

Dial-in Information

The company has provided comprehensive dial-in details for investors across multiple regions:

Additional Information

The earnings call information will also be available on the company's investor relations website at yatharthhospitals.com/investors. For further queries regarding the conference call, investors can contact Shrikant Akolkar at Nuvama Wealth Management Ltd. via email at Shrikant.Akolkar@nuvama.com .

The regulatory filing was signed by Ritesh Mishra, Company Secretary & Compliance Officer, and submitted to both NSE (Symbol: YATHARTH) and BSE (Scrip Code: 543950) on February 2, 2026.

Yatharth Hospital & Trauma Care Services Limited has successfully executed a Share Purchase Agreement (SPA) on January 29, 2026, to complete its acquisition of 100% interest in Shantived Institute of Medical Sciences located in Agra. The company made this announcement through a regulatory filing under Regulation 30 of SEBI's Listing Obligations and Disclosure Requirements Regulations, 2015.

Acquisition Timeline and Commercial Operations

The healthcare provider has outlined a clear timeline for integrating the acquired facility into its operations. Commercial operations at the target hospital are scheduled to commence from February 1st, 2026, marking a swift transition from agreement execution to operational launch.

Previous Disclosure and Regulatory Compliance

This latest development follows the company's earlier communication dated September 13, 2025, which initially disclosed the planned acquisition. The execution of the Share Purchase Agreement represents the culmination of the acquisition process that has been in progress for several months.

The company has ensured full regulatory compliance by filing the requisite disclosure with both the National Stock Exchange of India Limited and BSE Limited. The announcement was signed by Ritesh Mishra, Company Secretary & Compliance Officer, maintaining proper corporate governance protocols.

Expanding Healthcare Network

With this acquisition, Yatharth Hospital continues to strengthen its presence in the healthcare sector. The company currently operates multiple facilities across various locations including Greater Noida, Noida, Faridabad, New Delhi, and Madhya Pradesh. The addition of the Agra facility will further expand its geographical footprint and service capabilities.

The disclosure has been made available on the company's investor relations website at yatharthhospitals.com/investors, ensuring transparency and accessibility for stakeholders and investors.